Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Adrian F. Hernandez(Duke University), Lauren B. Cooper, Stephen J. Greene(Duke Medical Center), Thomas J. Povsic, Christopher B. Granger(Clinical Research Institute), Andrew P. Ambrosy(Kaiser Permanente), Jennifer B. Green, Stefano Del Prato(University of Pisa), J. Dedrick Jordan, Pierluigi Tricoci(CSL (United States)), John J.V. McMurray(University of Glasgow), Ralph B. D’Agostino(Wake Forest University), Nigel C. Jones(GlaxoSmithKline (United Kingdom)), Jay Shavadia, Rajendra Mehta, Brad J. Kolls, Aditya Mandawat, Anne E Rosenberg(Duke University), Shaun G. Goodman(University of Toronto), Matthew C. Somerville(PAREXEL International (United States)), David L. DeMets(University of Wisconsin–Madison), Rury R. Holman(University of Oxford), Karl M. Thorpe(GlaxoSmithKline (United Kingdom)), Chiara Melloni, Matthew T. Roe(Clinical Research Institute), David C. M. Kong, Robin Mathews, Renato D. Lópes(Duke University), Darren K. McGuire(Parkland Health & Hospital System), Gerald S. Bloomfield, Sreekanth Vemulapalli(Duke University), Lawrence A. Leiter(St. Michael's Hospital), Matthew C. Riddle(Oregon Health & Science University), Kristina N. Sigmon(Duke University), Chetan B. Patel, Karen Alexander, Adam D. DeVore, Keith Dombrowski, Zubin J. Eapen, Salim Janmohamed(GlaxoSmithKline (United Kingdom)), W. Schuyler Jones(Duke University), Robert M. Califf(Duke University), Robert W. Harrison(Georgia State University)
Cited by 1,781
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Prediction of Coronary Heart Disease Using Risk Factor Categories
|Circulation|1998|9.6k
General Cardiovascular Risk Profile for Use in Primary Care
|Circulation|2008|7.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k